# Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration

> **NCT02060604** · PHASE4 · COMPLETED · sponsor: **Università degli Studi di Brescia** · enrollment: 60 (actual)

## Conditions studied

- Wet Macular Degeneration

## Interventions

- **DRUG:** Ketorolac + Ranibizumab
- **DRUG:** Ranibizumab

## Key facts

- **NCT ID:** NCT02060604
- **Lead sponsor:** Università degli Studi di Brescia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02060604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02060604, "Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular Degeneration". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02060604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*